Valeant Will Release Fourth-Quarter and Full-Year 2017 Financial Results On February 28

LAVAL, Quebec, Feb. 6, 2018 /PRNewswire/ -- Valeant will release its fourth-quarter and full-year 2017 financial results on Wednesday, Feb. 28, 2018. Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.

    Conference Call Details

    Date:                   Wednesday, Feb. 28, 2018

    Time:                   8:00 a.m. EST

    Webcast:                http://ir.valeant.com/events-and-presentations

    Participant
     Event Dial-
     in:                    (844) 428-3520 (North America)

                            (409) 767-8386 (International)

    Participant
     Passcode:                                                             5287247

    Replay Dial-in:         (855) 859-2056 (North America)

                            (404) 537-3406 (International)

    Replay
     Passcode:              5287247 (replay available until Apr. 28, 2018)

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

    Investor Contact:          Media Contact:

    Arthur Shannon             Lainie Keller

    arthur.shannon@valeant.com lainie.keller@valeant.com

    (514) 856-3855             (908) 927-0617

    (877) 281-6642 (toll free)

View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-will-release-fourth-quarter-and-full-year-2017-financial-results-on-february-28-300594219.html

SOURCE Valeant Pharmaceuticals International, Inc.